
European Journal of Medicinal Chemistry p. 179 - 190 (1995)
Update date:2022-08-02
Topics:
Tanaka, M.
Kaneko, T.
Akamatsu, H.
Okita, M.
Chiba, K.
et al.
A series of (E)-3-(4-hydroxy-5-methoxyindole-7-yl)-2-methylpropenoic acids was prepared and the inhibitory activities of its members on IL-1 generation were evaluated in an in vivo system using the rat caboxymethyl cellulose-lipopolysaccharide (CMS-LPS) air-pouch model.Many compounds in this new series were found to be inhibitors of IL-1 generation.Structure-activity relationships indicated that a methyl substituent at the 1- and 3-positions on the indole ring are important for activity and that a 3,4,5-trimethoxy-substituted 2-phenyl group on the indole ring is suitable to give compounds exhibiting inhibition after oral administration.Among the compounds evaluated, (E)-3-<1,3-dimethyl-4-hydroxy-5-methoxy-2-(3,4,5-trimethoxyphenyl)indole-7-yl>-2-methylpropenoic acid (15m), which inhibited IL-1 generation by human monocytes stimulated with various reagents such as LPS, opsonized zymosan and immune complexes, showed inhibitory activity in the rat CMC-LPS model after oral administration. hydroxyindole derivative/ inhibitor of IL-1 generation/ rat CMC-LPS air-pouch model
View MoreAnhui Dexinjia Biopharm Co., Ltd
Contact:+86-531-82375818
Address:9 Hexie Road, kaifaqu, Taihe
Jinan Yufeng Bioengineering Co., Ltd.
Contact:+86-531-83130545/83130528/83130525/83130505
Address:Rm415,Building2,No19,Huaneng Road,Jinan, Shandong, China
Contact:--
Address:80G, No.1 Building, Guodu Development Mansion, No. 182 Zhaohui Road, Hangzhou City, Zhejiang Province,China.
Lianyungang Ningkang Chemical Co., Ltd
Contact:.+86-518-88588008
Address:http://www.chemnk.com
Nanjing Ruizhi Industry & Technologh Co.,Ltd.
Contact:+86-25-86808110
Address:441-4-A5,NO.12 Longzang Avenue,Yuhuatai District,210039,Nanjing
Doi:10.1007/BF00699146
(1994)Doi:10.1039/DT9950001653
(1995)Doi:10.1016/0020-1693(94)04315-M
()Doi:10.1039/b502416a
(2005)Doi:10.1021/jo971928l
(1998)Doi:10.1016/j.chempr.2018.06.001
(2018)